Answers are grounded in this paper and cite their sources.
Objective: The aim of this study is to determine the distribution of blood components by hospitals, to obtain information on hospital preferences for blood products, to determine the quantities of blood products requested and used, and to examine rates of noncompliance with blood product requirements. Material and Method: This is a single-centre retrospective study conducted between January 2021 and December 2023. In this study, we retrospectively analysed the changes in the number of blood transfusions, blood products, inpatients and outpatients. Results: In our study, a total of 8702 units of blood products including 5705 units of erythrocyte suspension (65.63%), 2750 units of fresh frozen plasma (31.63%), 183 units of pooled platelets (2.10%), 54 cryoprecipitate (0.62%) were used in Etlik Zübeyde Hanım Gynaecology and Obstetrics Training and Research Hospital in the last 3 years. Conclusion: Erythrocyte suspension was the most commonly used blood product in the last 3 years. The least used blood product was cryoprecipitate. Due to supply options and transfusion combinations, blood transfusion should be individualised considering the cost-benefit ratio. Case-by-case assessment of blood transfusion rates would be useful to achieve a significant reduction in blood transfusion collection and especially disposal rates.
No takes yet. Share an insight, caveat, or question.
Karadeniz et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: